In a rat model of type 2 diabetes, GW0742 was shown to reduce the proinflammatory cytokines tumor necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) in liver tissues, in conjunction with reduced hepatic fat accumulation [56]. Here, CCL2 is linked to type 2 diabetes mellitus.